Top Markets
Coin of the day
Addex Therapeutics Ltd Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXN
Hisse Senetlerindeki Sıralama #33376
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase,... Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.
Hisse Fiyatı
$0.05124204
Piyasa Değeri
$7.78M
Değişim (1 gün)
0.51%
Değişim (1 yıl)
-23.73%
Ülke
CH
Ticaret Addex Therapeutics Ltd (ADXN)

Kategori

Addex Therapeutics Ltd (ADXN) için P/S oranı
2026 itibarıyla P/S oranı TTM: 0
Addex Therapeutics Ltd şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 0'dir. 2026 yılının sonunda şirketin P/S oranı 0 idi.
Addex Therapeutics Ltd için P/S oranı geçmişi 2026 - 2026 arası
Her yılın sonunda P/S oranı
Yıl P/S Oranı Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için P/S oranı
Şirket P/S Oranı P/S Oranı Farkı Ülke
10.17 -
US
10.13 -
NL
- -
CH
- -
KR
4.74 -
BE